Literature DB >> 2493088

In vitro development of Neospora caninum (Protozoa: Apicomplexa) from dogs.

D S Lindsay1, J P Dubey.   

Abstract

The development of Neospora caninum isolated from naturally infected dogs was examined in mammalian cell cultures. Tachyzoites developed by endodyogeny when inoculated onto bovine monocyte or bovine cardiopulmonary artery endothelial cell cultures. Tachyzoites were 5.0 by 2.0 microns and had a posteriorly located nucleus. Cytopathogenic effects of parasite development consisted of the formation of holes in the cell monolayer associated with the rupture of infected host cells. Serial passage of tachyzoites was achieved by subinoculation of tachyzoites onto non-infected bovine monocyte cell cultures. It appears that N. caninum can be continuously grown in cell cultures.

Entities:  

Mesh:

Year:  1989        PMID: 2493088

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  10 in total

1.  Gene discovery in the apicomplexa as revealed by EST sequencing and assembly of a comparative gene database.

Authors:  Li Li; Brian P Brunk; Jessica C Kissinger; Deana Pape; Keliang Tang; Robert H Cole; John Martin; Todd Wylie; Mike Dante; Steven J Fogarty; Daniel K Howe; Paul Liberator; Carmen Diaz; Jennifer Anderson; Michael White; Maria E Jerome; Emily A Johnson; Jay A Radke; Christian J Stoeckert; Robert H Waterston; Sandra W Clifton; David S Roos; L David Sibley
Journal:  Genome Res       Date:  2003-03       Impact factor: 9.043

2.  Identification and characterization of Neospora caninum cyclophilin that elicits gamma interferon production.

Authors:  Wenbin Tuo; Raymond Fetterer; Mark Jenkins; J P Dubey
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Inhibitory activities of epidermal growth factor receptor tyrosine kinase-targeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum development.

Authors:  G Gargala; A Baishanbo; L Favennec; A François; J J Ballet; J-F Rossignol
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Quantitative detection of Neospora caninum in bovine aborted fetuses and experimentally infected mice by real-time PCR.

Authors:  Esther Collantes-Fernández; Angel Zaballos; Gema Alvarez-García; Luis M Ortega-Mora
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

5.  Immunization of BALB/c mice with killed Neospora caninum tachyzoite antigen induces a type 2 immune response and exacerbates encephalitis and neurological disease.

Authors:  T V Baszler; T F McElwain; B A Mathison
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

6.  Comparative study of protective activities of Neospora caninum bradyzoite antigens, NcBAG1, NcBSR4, NcMAG1, and NcSAG4, in a mouse model of acute parasitic infection.

Authors:  Masaki Uchida; Kotomi Nagashima; Yui Akatsuka; Takashi Murakami; Akira Ito; Soichi Imai; Kazunori Ike
Journal:  Parasitol Res       Date:  2012-11-15       Impact factor: 2.289

7.  Genetic comparison of Neospora caninum with Toxoplasma and Sarcocystis by random amplified polymorphic DNA-polymerase chain reaction.

Authors:  Z G Guo; A M Johnson
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

8.  Characterization of anti-Neospora caninum hyperimmune rabbit serum by western blot analysis and immunoelectron microscopy.

Authors:  J R Barta; J P Dubey
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

9.  Infection of mice with Neospora caninum (Protozoa: Apicomplexa) does not protect against challenge with Toxoplasma gondii.

Authors:  D S Lindsay; B L Blagburn; J P Dubey
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

10.  Copro-molecular diagnosis of the Toxoplasmatinae subfamily in dog and cat populations in northern Iran.

Authors:  Leila Izadi; Shahabeddin Sarvi; Seyed Abdollah Hosseini; Afsaneh Amouei; Mehdi Sharif; Mohammad Taghi Rahimi; Tooran Nayeri; Ahmad Daryani
Journal:  Epidemiol Health       Date:  2020-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.